0001213900-17-013264.txt : 20180118 0001213900-17-013264.hdr.sgml : 20180118 20171214173058 ACCESSION NUMBER: 0001213900-17-013264 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20171214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Akers Biosciences, Inc. CENTRAL INDEX KEY: 0001321834 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 201 GROVE RD CITY: THOROFARE STATE: NJ ZIP: 08086 BUSINESS PHONE: 856-848-8698 MAIL ADDRESS: STREET 1: 201 GROVE RD CITY: THOROFARE STATE: NJ ZIP: 08086 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences Inc DATE OF NAME CHANGE: 20050325 CORRESP 1 filename1.htm

Akers Biosciences, Inc.

201 Grove Road

Thorofare, NJ 08086

(856) 848-2116

December 14, 2017

VIA EDGAR

United States Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

Attention: Irene Paik and Erin Jaskot

	*Re:*	*Akers Biosciences, Inc. – Withdrawal of Acceleration Request*
		*Registration Statement on Form S-1*
		*File No. 333- 221746*

Ladies and Gentlemen:

Reference is made to our letter, filed as correspondence via EDGAR on December 13, 2017, in which we requested the acceleration of the effective date of the above-referenced Registration Statement for Thursday, December 14, 2017, at 5:00 p.m. Eastern Time, in accordance with Rule 461 under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

	AKERS BIOSCIENCES, INC.

	By:	/s/ John J. Gormally
		John J. Gormally Chief Executive Officer